Opus Genetics (IRD) Net Cash Flow Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 198.34% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 467.41% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -14,223.53% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 453.08% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -125.22% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 53.46% |
| 10 | Opus Genetics | 357.99 Mn | 298.03 Mn | - | 29.61% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.61% |
| Dec 31, 2025 | 326.21% |
| Sep 30, 2025 | 66.21% |
| Jun 30, 2025 | -62.78% |
| Mar 31, 2025 | 443.44% |
| Dec 31, 2024 | -177.43% |
| Sep 30, 2024 | -301.31% |
| Jun 30, 2024 | -681.60% |
| Mar 31, 2024 | 8.39% |
| Dec 31, 2023 | -71.68% |
| Sep 30, 2023 | 174.86% |
| Jun 30, 2023 | 144.53% |
| Mar 31, 2023 | 31.05% |
| Dec 31, 2022 | 1,160.03% |
| Sep 30, 2022 | -59.78% |
| Jun 30, 2022 | -116.29% |
| Mar 31, 2022 | 8.86% |
| Dec 31, 2021 | -85.43% |
| Sep 30, 2021 | -1,403.03% |
| Jun 30, 2021 | 3,517.79% |
| Mar 31, 2021 | -1,942.96% |
| Dec 31, 2020 | 725.89% |
| Sep 30, 2020 | -121.22% |
| Jun 30, 2020 | -133.61% |
| Mar 31, 2020 | 89.17% |
| Dec 31, 2019 | 172.44% |
| Sep 30, 2019 | 223.78% |
| Jun 30, 2019 | 198.61% |
| Mar 31, 2019 | -0.79% |
| Dec 31, 2018 | -489.35% |
| Sep 30, 2018 | 10.95% |
| Jun 30, 2018 | 28.99% |
| Mar 31, 2018 | -138.11% |
| Dec 31, 2017 | -78.88% |
| Sep 30, 2017 | -209.74% |
| Jun 30, 2017 | 34.42% |
| Mar 31, 2017 | -513.41% |
| Dec 31, 2016 | 241.55% |
| Sep 30, 2016 | -79.26% |
| Jun 30, 2016 | -240.86% |
| Mar 31, 2016 | -70.74% |
| Dec 31, 2015 | 56.25% |
| Sep 30, 2015 | 110.72% |
| Jun 30, 2015 | 61.47% |
| Mar 31, 2015 | -95.78% |
| Dec 31, 2014 | -234.80% |
| Sep 30, 2014 | -572.90% |
| Jun 30, 2014 | 6.99% |
| Mar 31, 2014 | 1,608.63% |
| Dec 31, 2013 | 295.94% |
| Sep 30, 2013 | 543.49% |
| Jun 30, 2013 | -654.23% |
| Mar 31, 2013 | 19.48% |
| Dec 31, 2012 | 41.94% |
| Sep 30, 2012 | 62.11% |
| Jun 30, 2012 | 108.71% |
| Mar 31, 2012 | -121.54% |
| Dec 31, 2011 | 3.84% |
| Sep 30, 2011 | -46.64% |